Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AIR Algorithm study in adult asthma
ACTRN12620001010987Phase 4Completed
- Sponsor
- Medical Research Institute of New Zealand
- Start
- Dec 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of budesonide and formoterol in asthma, sponsored by Medical Research Institute of New Zealand. Primary endpoints: Treatment satisfaction at 26 weeks and Treatment satisfaction at 52 weeks. Started Dec 2020; status: completed.
02
Drugs
budesonideformoterol
03
Conditions
asthma
Beyond the preview
Go deeper on ACTRN12620001010987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12620001010987.